| Preface |
|
xi | |
| Acknowledgments |
|
xiii | |
| I. UPPER RESPIRATORY TRACT |
|
|
Tonsillopharyngitis in Adults |
|
|
3 | (5) |
|
|
|
8 | (5) |
|
Infectious Mononucleosis: Many Faces of a Common Disease |
|
|
13 | (8) |
| II. LOWER RESPIRATORY TRACT |
|
|
|
|
21 | (3) |
|
Antibiotic-resistant Pneumococci |
|
|
24 | (3) |
|
Fever and Pleural Effusions |
|
|
27 | (7) |
|
Pneumonia in the Intensive Care Unit |
|
|
34 | (8) |
|
Community-acquired Pneumonia in the Geriatric Patient |
|
|
42 | (4) |
|
Disease Caused by Legionella pneumophila and Chlamydia pneumoniae |
|
|
46 | (11) |
| III. CARDIOVASCULAR SYSTEM |
|
|
Infective Endocarditis: Diagnostic Criteria |
|
|
57 | (4) |
|
Culture-negative Endocarditis |
|
|
61 | (3) |
|
Surgery in Active Infective Endocarditis |
|
|
64 | (4) |
|
|
|
68 | (9) |
| IV. GASTROINTESTINAL SYSTEM |
|
|
Filling Defects of the Liver |
|
|
77 | (5) |
|
|
|
82 | (3) |
|
Community-acquired Peritonitis |
|
|
85 | (7) |
|
Infections of the Hepatobiliary Tract |
|
|
92 | (9) |
| V. URINARY TRACT |
|
|
Urinary Tract Infections: Basic Principles of Therapy |
|
|
101 | (2) |
|
Cystitis Versus Pyelonephritis: Localizing Urinary Tract Infections |
|
|
103 | (3) |
|
|
|
106 | (3) |
|
The Significance of Pyuria |
|
|
109 | (2) |
|
|
|
111 | (4) |
|
Complicated Urinary Tract Infections |
|
|
115 | (4) |
|
|
|
119 | (6) |
| VI. GENITAL TRACT |
|
|
|
|
125 | (4) |
|
Serologic Tests for Syphilis |
|
|
129 | (5) |
|
Pelvic Inflammatory Disease |
|
|
134 | (4) |
|
Therapy of Genital Herpes |
|
|
138 | (5) |
|
|
|
143 | (8) |
| VII. NERVOUS SYSTEM |
|
|
Analysis of Cerebrospinal Fluid |
|
|
151 | (6) |
|
Central Nervous System Infections in the Compromised Host |
|
|
157 | (5) |
|
New Onset of Facial Paralysis |
|
|
162 | (5) |
|
Acute Infections of the Central Nervous System |
|
|
167 | (9) |
|
|
|
176 | (6) |
|
|
|
182 | (7) |
| VIII. BONES AND JOINTS |
|
|
|
|
189 | (4) |
|
Infections of Prosthetic Joints |
|
|
193 | (5) |
|
|
|
198 | (7) |
| IX. SKIN AND SOFT TISSUE |
|
|
Infectious Disease Indications for Hyperbaric Oxygen Therapy |
|
|
205 | (4) |
|
Lyme Disease---A Diagnostic Challenge |
|
|
209 | (6) |
|
Cellulitis and Other Skin and Soft-Tissue Infections |
|
|
215 | (8) |
| X. BACTEREMIA |
|
|
Gram-negative Bacteremia and the Sepsis Cascade |
|
|
223 | (6) |
|
Methicillin-resistant Staphylococcus aureus |
|
|
229 | (5) |
|
Coagulase-negative Staphylococci |
|
|
234 | (3) |
|
Vancomycin-resistant Enterococci |
|
|
237 | (8) |
| XI. FEVER |
|
|
The Febrile Patient without an Obvious Source of Infection |
|
|
245 | (3) |
|
Fever and Prosthetic Heart Valves |
|
|
248 | (5) |
|
Prolonged Fever and Generalized Lymphadenopathy |
|
|
253 | (3) |
|
|
|
256 | (8) |
|
Fever and the Renal Transplant Recipient |
|
|
264 | (6) |
|
Fever Following Travel Abroad |
|
|
270 | (6) |
|
Hyperpyrexia and Hyperthermia |
|
|
276 | (6) |
|
Fever in the Granulocytopenic Patient |
|
|
282 | (6) |
|
|
|
288 | (5) |
|
|
|
293 | (10) |
| XII. IMMUNITY |
|
|
Management of the Patient with Suspected β-Lactam Allergy |
|
|
303 | (8) |
| XIII. NOSOCOMIAL INFECTIONS |
|
|
|
|
311 | (5) |
|
Urinary Catheter-related Infections |
|
|
316 | (6) |
|
Hospital-acquired (Nosocomial) Pneumonia |
|
|
322 | (6) |
|
Management of the Employee with a Needlestick Injury |
|
|
328 | (8) |
|
|
|
336 | (9) |
| XIV. ZOONOSES |
|
|
Human Infections Following Animal Bites |
|
|
345 | (6) |
| XV. NEWLY APPRECIATED INFECTIONS |
|
|
New and Increasingly Recognized Pathogens |
|
|
351 | (6) |
| XVI. PROPHYLAXIS OF INFECTION IN TRAVELERS |
|
|
Prophylaxis of Infectious Diseases in Travelers |
|
|
357 | (8) |
| XVII. TUBERCULOSIS |
|
|
Role of the Tuberculin Skin Test |
|
|
365 | (5) |
|
Isoniazid Chemoprophylaxis: Indications and Management |
|
|
370 | (6) |
|
Chemotherapy of Tuberculosis |
|
|
376 | (9) |
| XVIII. SELECTED LABORATORY PROCEDURES |
|
|
Laboratory Report of a Gram-negative Rod in the Blood |
|
|
385 | (4) |
|
Blood Culture Growing a Gram-positive Rod |
|
|
389 | (3) |
|
Stool for Ova and Parasites |
|
|
392 | (3) |
|
Antimicrobial Susceptibility Tests |
|
|
395 | (5) |
|
Special Tests of Antimicrobial Activity in Infectious Diseases |
|
|
400 | (7) |
| XIX. ANTIMICROBIAL, ANTIVIRAL, ANTIPARASITIC, AND ANTIFUNGAL AGENTS |
|
|
Principles of Antimicrobial Therapy |
|
|
407 | (3) |
|
|
|
410 | (4) |
|
Single Daily Dosing of Aminoglycosides |
|
|
414 | (3) |
|
Antimicrobial-associated Colitis |
|
|
417 | (4) |
|
Perioperative Antimicrobial Prophylaxis |
|
|
421 | (5) |
|
|
|
426 | (7) |
|
|
|
433 | (4) |
|
|
|
437 | (4) |
|
Who Really Needs Parenteral Antibiotics? |
|
|
441 | (8) |
| XX. AIDS |
|
|
Acquisition and Transmission of HIV |
|
|
449 | (3) |
|
Primary HIV Infection (HIV-Mononucleosis Syndrome) |
|
|
452 | (3) |
|
Treatment of Pneumocystis carinii Pneumonia in AIDS |
|
|
455 | (5) |
|
Tuberculosis and Syphilis in the AIDS Era |
|
|
460 | (6) |
|
HIV-1 and Infections of the Central Nervous System |
|
|
466 | (8) |
|
Disseminated Mycobacterium avium Complex Infection |
|
|
474 | (4) |
|
Fever and Fever of Unknown Origin in the HIV-infected Patient |
|
|
478 | (4) |
|
Prevention of Opportunistic Infection in the HIV-infected Patient |
|
|
482 | (3) |
|
|
|
485 | (8) |
|
Drug Interactions in Patients with Human Immunodeficiency Syndrome |
|
|
493 | (6) |
| Subject Index |
|
499 | |